The information below is provided as an honest informational reference for patients researching their growth hormone peptide options
IV therapy delivers larger doses (250-1,000mg) directly into the bloodstream with near-complete absorption, making it better for loading phases or when rapid results are the priority
The evidence is still early
Any appetite-related changes are secondary: as sleep improves, energy returns, and body composition shifts, patients naturally feel more motivated to support those changes with better nutrition
Retatrutide is investigational and not approved for human use
When selecting fruits, focus on whole foods rather than juices, since juices lack fiber and may cause digestive discomfort when combined with GLP-1 medications